Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020)

Argenx Se (ARGX) posted quarterly Current Deferred Revenue of $292.5 million for Q4 2020, down 11.49% year-on-year from $330.4 million in Q1 2020, and up 281.91% on a QoQ basis from $76.6 million in Q2 2020.

Argenx Se (ARGX) Current Deferred Revenue (2015 - 2020) Analysis & Trends

Argenx Se (ARGX) has reported Current Deferred Revenue for 6 consecutive years, with $292.5 million the latest figure, recorded in Q4 2020.

  • Quarterly Current Deferred Revenue fell 11.49% year-over-year to $292.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $292.5 million (down 11.49% YoY) and the FY2020 annual result came in at $46.3 million, down 42.99% from the prior year.
  • Current Deferred Revenue grew to $292.5 million in Q4 2020 per ARGX's latest filing, from $76.6 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for ARGX reached as high as $330.4 million in Q4 2019 and fell as low as $2.5 million in Q4 2018.
  • A 5-year average of $93.3 million and a median of $31.1 million in 2017 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2018 — Current Deferred Revenue slumped 86.6% — and 2019, when it jumped 13336.88%.
  • Year by year, Current Deferred Revenue stood at $29.1 million in 2016, then plunged by 36.83% to $18.4 million in 2017, then sank by 86.6% to $2.5 million in 2018, then soared by 13336.88% to $330.4 million in 2019, then decreased by 11.49% to $292.5 million in 2020.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $292.5 million, $76.6 million, and $330.4 million for Q4 2020, Q2 2020, and Q4 2019 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 292.46 Mn
Jun 30, 2020 76.58 Mn
Dec 31, 2019 330.43 Mn
Jun 30, 2019 52.19 Mn
Dec 31, 2018 2.46 Mn
Jun 30, 2018 7.09 Mn
Dec 31, 2017 18.36 Mn
Jun 30, 2017 31.13 Mn
Dec 31, 2016 29.06 Mn
Dec 31, 2015 5.98 Mn